Argitalpenak (222) VICENTE ESTRADA PÉREZ argitalpenak

2024

  1. A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 79, Núm. 4, pp. 910-919

  2. A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection

    Journal of Medical Virology, Vol. 96, Núm. 5

  3. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  4. Cost analysis associated with intramuscular versus oral administration of antiretroviral therapy in the management of human immunodeficiency virus infection

    Enfermedades Infecciosas y Microbiologia Clinica

  5. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

    The Lancet Microbe, Vol. 5, Núm. 6, pp. e559-e569

  6. Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users

    Enfermedades Infecciosas y Microbiologia Clinica

  7. Inflammation in HIV: A persistent challenge

    Enfermedades Infecciosas y Microbiologia Clinica

  8. Monkeypox virus genomic accordion strategies

    Nature Communications, Vol. 15, Núm. 1

  9. Mpox, herpes, and enteroviruses: Differential diagnosis

    Journal of Medical Virology

  10. Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience

    Enfermedades Infecciosas y Microbiologia Clinica

  11. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine

  12. Subclinical atherosclerosis burden in carotid and femoral territories in HIV subjects: relationships with HIV and non-HIV related factors

    BMC Infectious Diseases, Vol. 24, Núm. 1

  13. T Cell Homeostasis Disturbances in a Cohort of Long-Term Elite Controllers of HIV Infection

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

2023

  1. Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19

    Infectious Diseases Now, Vol. 53, Núm. 7

  2. Differences in the inflammatory response among hospitalized patients with distinct variants of SARS-CoV-2

    Frontiers in Immunology, Vol. 14

  3. Faster lung function decline in people living with HIV despite adequate treatment: A longitudinal matched cohort study

    Thorax, Vol. 78, Núm. 6, pp. 535-542

  4. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  5. Impact of the COVID-19 pandemic on the mental health of the general population and health care workers

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 125-143

  6. Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study

    The Lancet Microbe, Vol. 4, Núm. 1, pp. e21-e28

  7. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1